Volume 2, Number 1, January-February-March 2009

EDITORIALA life in three parts
Professor Michael Kirby

POPULAR
TOPICORIGINAL RESEARCHAge cut-off for aspirin therapy to prevent cardiovascular disease in patients without diabetes
Iskandar Idris

Aspirin has been demonstrated to be effective in the prevention of cardiovascular disease in patients without overt CVD. Guidelines recommend consideration of its use based on annual risk of coronary heart disease. But is there an argument for a more pragmatic approach based on age alone?

JOURNAL REVIEWJournal Review

POPULAR
TOPICTOPICAL REVIEWSmoking cessation 1: choosing the right pharmacotherapy for each patient
Paul Aveyard, Amanda Parsons, Rachna Begh

TOPICAL REVIEWSmoking cessation 2: nicotine replacement therapy – new tricks with old drugs
Paul Aveyard, Amanda Parsons, Rachna Begh

POPULAR
TOPICTOPICAL REVIEWWhen is coronary revascularisation superior to medical therapy in patients with angina?
Smriti Saraf, Diana Gorog

POPULAR
TOPICPRIMARY CARE VIEWGive medical therapy a chance
Alan Begg

POPULAR
TOPICPRIMARY CARE VIEWAspirin in patients with and without diabetes
Alan Begg

GUIDELINESA Summary Of The Nice Guideline For Detecting And Managing Chronic Kidney Disease (CKD)

POPULAR
TOPICEVIDENCE REVIEWCardiovascular risk management series: 3 - Identifying high-risk patients
Arno W Hoes, Elinor Washbrook, Rodney Jackson

CASE REVIEWA case of paediatric hypertension
Ahmet Fuat

This series of reflective case studies presents the history, examination and test results for ‘real life’ primary care patients, followed by assessment of the evidence indicating what constitutes best practice.

DRUG REVIEWAre new oral anticoagulant drugs set to transfer provision of anticoagulation services to primary care?
David Fitzmaurice, Peter Rose, Ellen Murray

TRIAL REVIEWThe UK Prospective Diabetes Study (UKPDS): Its legacy for type 2 diabetes management
Ian W Campbell

NEWSNews stories in this issue...